John Flavin
Founder and CEO of life sciences venture firm Portal Innovations, speaking about pharma M&A, biotech themes, and sector outlook for 2026.
Best podcasts with John Flavin
Ranked by the Snipd community
Dec 24, 2025 • 42min
SOTS 2nd Hour: Jeremy Siegel, Crypto’s Newest Lobbying Effort, Outlook for Pharam M&A 12/24/25
Jeremy Siegel, renowned Wharton School professor and WisdomTree chief economist, provides insights on recent jobless claims and potential market risks. Mark Zandi, chief economist at Moody's Analytics, discusses the fragility of growth despite low layoffs and critiques inflation metrics. John Flavin, CEO of Portal Innovations, shares his take on the recent Sanofi-Dynavax deal and predicts a robust year for pharma M&A in 2026, highlighting investment themes like AI's impact on drug discovery and therapeutic advancements.
Nov 20, 2025 • 44min
Stocks Drop In Major Reversal… And Opportunities In A Red-Hot Biotech Sector 11/20/25
Mike Coe, a savvy trader known for his short-term strategies, and John Flavin, CEO of Portal Innovation, dive into market fluctuations and the booming biotech sector. They discuss why Nvidia's disappointing earnings sparked a market sell-off and how Walmart shone amidst the chaos. Flavin highlights the surge in biotech valuations driven by M&A activity, strong scientific advancements, and state funding, particularly in Texas, making it an exciting time for life science startups.
